Allianz Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $10.4M | Buy |
74,800
+7,200
| +11% | +$1.01M | 0.01% | 855 |
|
|
2025
Q4 | $8.3M | Buy |
67,600
+7,000
| +12% | +$851K | 0.01% | 925 |
|
|
2025
Q3 | $6.73M | Sell |
60,600
-26,100
| -30% | -$2.97M | 0.01% | 992 |
|
|
2025
Q2 | $9.61M | Buy |
86,700
+21,500
| +33% | +$2.29M | 0.01% | 832 |
|
|
2025
Q1 | $7.31M | Sell |
65,200
-40,300
| -38% | -$4.16M | 0.01% | 919 |
|
|
2024
Q4 | $9.75M | Sell |
105,500
-13,700
| -11% | -$1.23M | 0.01% | 757 |
|
|
2024
Q3 | $9.99M | Buy |
119,200
+33,600
| +39% | +$2.56M | 0.01% | 738 |
|
|
2024
Q2 | $5.87M | Buy |
85,600
+54,400
| +174% | +$3.63M | 0.01% | 888 |
|
|
2024
Q1 | $2.29M | Sell |
31,200
-78,600
| -72% | -$6.04M | ﹤0.01% | 1138 |
|
|
2023
Q4 | $8.89M | Sell |
109,800
-61,900
| -36% | -$4.82M | 0.01% | 722 |
|
|
2023
Q3 | $12.9M | Buy |
171,700
+23,400
| +16% | +$1.8M | 0.02% | 628 |
|
|
2023
Q2 | $11.4M | Buy |
148,300
+13,400
| +10% | +$1.07M | 0.02% | 605 |
|
|
2023
Q1 | $11.2M | Buy |
134,900
+25,500
| +23% | +$2.11M | 0.02% | 654 |
|
|
2022
Q4 | $9.39M | Buy |
109,400
+30,600
| +39% | +$2.42M | 0.02% | 704 |
|
|
2022
Q3 | $4.86M | Buy |
78,800
+59,800
| +315% | +$3.77M | 0.01% | 894 |
|
|
2022
Q2 | $1.17M | Sell |
19,000
-59,100
| -76% | -$3.66M | ﹤0.01% | 1619 |
|
|
2022
Q1 | $4.64M | Buy |
78,100
+9,600
| +14% | +$614K | ﹤0.01% | 1255 |
|
|
2021
Q4 | $4.97M | Sell |
68,500
-33,900
| -33% | -$2.33M | ﹤0.01% | 1240 |
|
|
2021
Q3 | $7.15M | Buy |
102,400
+63,400
| +163% | +$4.45M | 0.01% | 1140 |
|
|
2021
Q2 | $2.69M | Sell |
39,000
-8,800
| -18% | -$588K | ﹤0.01% | 1372 |
|
|
2021
Q1 | $3.09M | Buy |
+47,800
| New | +$3.08M | ﹤0.01% | 1242 |
|
|
2020
Q3 | – | Sell |
-137,700
| Closed | -$10.6M | – | 2066 |
|
|
2020
Q2 | $10.6M | Sell |
137,700
-53,600
| -28% | -$4.11M | 0.01% | 865 |
|
|
2020
Q1 | $14.3M | Sell |
191,300
-84,000
| -31% | -$5.8M | 0.02% | 684 |
|
|
2019
Q4 | $17.9M | Sell |
275,300
-14,400
| -5% | -$938K | 0.02% | 838 |
|
|
2019
Q3 | $18.4M | Sell |
289,700
-84,800
| -23% | -$5.54M | 0.02% | 808 |
|
|
2019
Q2 | $25.3M | Buy |
374,500
+103,400
| +38% | +$6.8M | 0.02% | 708 |
|
|
2019
Q1 | $17.6M | Sell |
271,100
-176,500
| -39% | -$11.7M | 0.02% | 813 |
|
|
2018
Q4 | $28M | Sell |
447,600
-129,000
| -22% | -$9.02M | 0.03% | 570 |
|
|
2018
Q3 | $44.5M | Sell |
576,600
-112,100
| -16% | -$8.47M | 0.04% | 485 |
|
|
2018
Q2 | $48.8M | Buy |
688,700
+22,600
| +3% | +$1.6M | 0.05% | 415 |
|
|
2018
Q1 | $50.2M | Sell |
666,100
-1,312,800
| -66% | -$104M | 0.05% | 425 |
|
|
2017
Q4 | $142M | Buy |
1,978,900
+193,300
| +11% | +$14.7M | 0.11% | 215 |
|
|
2017
Q3 | $145M | Buy |
1,785,600
+492,800
| +38% | +$37.7M | 0.12% | 183 |
|
|
2017
Q2 | $91.5M | Sell |
1,292,800
-59,200
| -4% | -$3.94M | 0.09% | 266 |
|
|
2017
Q1 | $91.8M | Sell |
1,352,000
-1,418,800
| -51% | -$99.8M | 0.09% | 262 |
|
|
2016
Q4 | $198M | Buy |
2,770,800
+978,300
| +55% | +$72.7M | 0.18% | 121 |
|
|
2016
Q3 | $142M | Buy |
1,792,500
+303,200
| +20% | +$24.6M | 0.14% | 162 |
|
|
2016
Q2 | $124M | Buy |
1,489,300
+640,000
| +75% | +$56.8M | 0.13% | 172 |
|
|
2016
Q1 | $78M | Buy |
849,300
+128,700
| +18% | +$11.6M | 0.09% | 229 |
|
|
2015
Q4 | $72.9M | Buy |
720,600
+233,200
| +48% | +$24.3M | 0.08% | 250 |
|
|
2015
Q3 | $47.9M | Sell |
487,400
-268,100
| -35% | -$29.8M | 0.06% | 395 |
|
|
2015
Q2 | $88.5M | Buy |
755,500
+225,100
| +42% | +$24.6M | 0.09% | 229 |
|
|
2015
Q1 | $52M | Sell |
530,400
-113,900
| -18% | -$11.6M | 0.06% | 346 |
|
|
2014
Q4 | $60.7M | Buy |
644,300
+409,400
| +174% | +$42.3M | 0.07% | 335 |
|
|
2014
Q3 | $25M | Buy |
+234,900
| New | +$23M | 0.03% | 570 |
|
Other funds holding GILD
VCM
VPM
Allianz Asset Management's GILD Position: Q1 2026 in Review
Allianz Asset Management reduced its Gilead Sciences (GILD) stake by 23% in Q1 2026, selling an estimated $131M and leaving 3,094,227 shares worth $431M. The position accounts for 0.45% of the portfolio, ranked #34.
Allianz Asset Management first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $731M in Q2 2015. 2,310 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Allianz Asset Management held 3,094,227 shares of Gilead Sciences worth $431M as of Q1 2026.
- Allianz Asset Management sold 936,303 Gilead Sciences shares in Q1 2026, an estimated $131M.
- Gilead Sciences made up 0.45% of Allianz Asset Management's portfolio in Q1 2026, its #34 holding.
- Allianz Asset Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- Allianz Asset Management's Gilead Sciences position peaked at $731M in Q2 2015.
- 2,310 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Allianz Asset Management's 13F filing for Q1 2026, filed 11 May 2026.